Clinical Trials Browser

Breast Neoplasms, Male × Fluorodeoxyglucose F18 × Clear all

NCT01931709 2023-11-18

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

Phase NA Terminated

35 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT03295695 2020-12-04

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male

NCT01720602 2020-01-07

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Phase NA Completed

15 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT01806675 2019-10-03

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Phase 1/2 Completed

25 enrolled 14 charts

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory, Gliosarcoma, Breast Neoplasms, Male

NCT00362973 2016-12-28

PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer

Breast Neoplasms, Breast Neoplasms, Male

NCT00109785 2015-12-24

PET Scans in Patients With Locally Advanced Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male